Many factors, such as tumor type, histological grade, lymph node metastasis, estrogen receptor (ER), and progesterone receptor (PR), affect the treatment response and prognosis of BC (Jokar et al., 2021). The gene discussed is PGR; the disease is metastatic malignant neoplasm in the lymph nodes.